The study, published in the journal Neurocritical Care, was led by Farzad Azizi Zade, Irfaan Dar, Brandon Foreman, and Ulas Sunar, with affiliations at Ferdowsi University of Mashhad, Stony Brook University, and the University of Cincinnati. The team retrospectively analyzed data from 26 adults who had undergone multimodal neuromonitoring during their critical illness. Rather than relying on a single snapshot of brain function, the researchers segmented the continuous monitoring signals into 30-minute windows taken after each probe recalibration, ensuring that the features fed into their models reflected stable, well-calibrated measurements of the neurovascular system.

The central insight of the work is that consciousness is not purely an electrical phenomenon. EEG, the workhorse of neurocritical care monitoring, captures the synchronized firing of cortical neurons but offers only a limited view of the neurovascular unit—the tightly coupled system of neurons, glial cells, and blood vessels that sustains brain function. Cerebral blood flow, by contrast, reflects the metabolic and hemodynamic machinery that supports neural activity. The researchers hypothesized that combining these two modalities would give a machine learning classifier a richer, more robust signature of conscious brain states than either signal could provide alone.

To test this hypothesis, the team extracted a carefully curated set of features from both signals. On the EEG side, they computed band powers across the classic frequency ranges from delta through beta, along with two composite indices that have proven sensitive to states of awareness: the alpha–delta ratio, known as ADR, and the alpha divided by the sum of delta and theta power, known as ADTR, as well as total EEG power. On the blood flow side, they focused on low-frequency oscillations in perfusion, computing power in specific frequency bands including band IV spanning 0.027 to 0.073 hertz, band V spanning 0.01 to 0.027 hertz, and a broad band covering 0 to 0.5 hertz. These slow fluctuations in cerebral perfusion are thought to reflect the interplay of vascular regulation, autonomic influences, and intrinsic brain dynamics, and prior research has linked their disruption to traumatic brain injury.

The classification engine at the heart of the study was a random forest model, an ensemble machine learning method that builds many decision trees on random subsets of the data and aggregates their votes. Random forests are well suited to clinical datasets of modest size because they resist overfitting and provide a measure of feature importance. The researchers trained the model using K-fold cross-validation, a technique that repeatedly partitions the data so that every patient contributes to both training and testing, and they excluded highly correlated features—those with a correlation coefficient above 0.8—from simultaneous use, preventing redundant information from inflating performance estimates. Performance was summarized with the area under the receiver operating characteristic curve, or ROC–AUC, alongside accuracy, with confusion matrices reported for the best-performing feature combinations.

The results were striking. Multimodal feature combinations significantly outperformed models built on EEG features alone. The single best combination—EEG alpha–delta ratio, total EEG power, and two cerebral blood flow features from bands B and V—achieved a ROC–AUC of 0.86 and an accuracy of 82 percent. In clinical terms, that means the model could distinguish conscious from unconscious states in roughly four out of five monitoring windows, using information that is already being collected, or could readily be collected, at the bedside of critically ill patients. The finding that slow blood flow oscillations carried discriminative information that EEG lacked underscores the value of looking beyond electrical activity when probing the injured brain.

Perhaps the most forward-looking result came from two exploratory cases in which patients were monitored with diffuse correlation spectroscopy, or DCS, a noninvasive optical technique. DCS uses near-infrared laser light to measure blood flow in the microvasculature of the cortex by detecting fluctuations in the scattering of light caused by moving red blood cells. When the researchers applied the same feature framework to these noninvasive DCS measurements, the resulting predictions were concordant with those obtained using invasive cerebral blood flow probes. This is a crucial proof of concept: it suggests that the multimodal approach need not depend on surgically implanted monitors, opening a path toward noninvasive, real-time consciousness assessment in a far broader population of patients.

The clinical context makes the advance particularly timely. Studies of disorders of consciousness have repeatedly shown that standardized neurobehavioral assessments detect awareness in a substantial fraction of patients who appear unresponsive on routine bedside examination, a phenomenon sometimes called covert consciousness. Research in the intensive care unit has even demonstrated that some acutely injured but unresponsive patients show brain activation on task-based imaging, and that such covert cognition carries prognostic weight. Meanwhile, multimodal approaches combining FDG-PET imaging with EEG have improved both diagnosis and prognostication, and machine learning has been increasingly applied across the neuro-ICU to predict intracranial pressure crises, delayed cerebral ischemia, and surgical needs. The new study extends this trajectory by fusing hemodynamic and electrophysiological monitoring into a single classification framework tailored to the neurocritical care setting.

The technical foundations of the approach draw on a rich literature. Low-frequency oscillations in cerebral hemodynamics have been studied extensively in resting-state functional MRI and in optical imaging, and coupled oscillator models of cardiovascular and brain interactions provide a theoretical basis for why these slow rhythms carry information about brain state. Cross-frequency coupling between cerebral blood flow velocity and EEG has been documented in stroke patients, and quantitative EEG measures such as the alpha–delta ratio have long been used to track encephalopathy and recovery. By feeding these established physiological markers into a modern ensemble classifier, the researchers bridged classical neurophysiology and contemporary data science in a way that is designed to work with the noisy, artifact-laden signals typical of the intensive care environment.

The authors are careful to frame the work as a step toward, not a replacement for, clinical judgment. The study was retrospective, involved 26 adults, and used invasive monitoring data in most cases, so prospective validation in larger and more diverse cohorts will be essential before such models can inform decisions about withdrawing sedation, pursuing rehabilitation, or assessing prognosis. Nevertheless, the combination of 0.86 ROC–AUC performance, concordance with noninvasive optical monitoring, and support from an NIH Brain Initiative grant points toward a future in which bedside tools continuously integrate EEG and blood flow signals to give clinicians a real-time, quantitative read on consciousness. For the families of patients lying silently in the neuro-ICU, and for the physicians charged with deciding what those silences mean, such a tool could transform one of medicine’s most uncertain judgments into a measured, data-driven assessment of the injured brain’s capacity for awareness.

Subject of Research: Machine learning classification of consciousness in neurocritical care using combined EEG and cerebral blood flow features

Article Title: Binary Classification of Consciousness Using Cerebral Blood Flow and EEG Features

Article References: Zade, F. A., Dar, I., Foreman, B., & Sunar, U. (2026). Binary Classification of Consciousness Using Cerebral Blood Flow and EEG Features. Neurocritical Care. https://doi.org/10.1007/s12028-026-02603-2

Image Credits: AI Generated

DOI: 10.1007/s12028-026-02603-2

Keywords: consciousness, EEG, cerebral blood flow, machine learning, random forest, neurocritical care, disorders of consciousness, diffuse correlation spectroscopy, low-frequency oscillations, neuromonitoring, alpha-delta ratio, brain injury

Researchers analysing the high-resolution dataset from the Collaborative European Neuro Trauma Effectiveness Research in Traumatic Brain Injury study, known as CENTER-TBI, developed and tested a three-step framework for evaluating what they call annotation plausibility. Their work, published in the journal Neurocritical Care, examined more than 15,000 annotated interventions across 205 patients and found that a striking proportion of manually entered treatment records were physiologically implausible, a problem with serious consequences for the artificial intelligence tools increasingly built on such data.

The core difficulty is deceptively simple. High-frequency neuromonitoring has transformed neurocritical care research, enabling individualised treatment strategies and predictive models that detect rapid physiological changes. Yet the annotations that contextualise these signals are usually entered manually, often under pressure, and sometimes hours after the event. Staff at the 21 European centres participating in the CENTER-TBI high-resolution sub-study used a touch-screen interface in the ICM+ software to log interventions from nine predefined categories, ranging from osmotherapy and suctioning to physiotherapy and sedation changes. The fixed categories were designed to standardise documentation across centres, but the process remained vulnerable to human error, inconsistency and temporal imprecision.

Those weaknesses matter enormously for modern data science. Supervised machine learning models assume that their training labels are accurate, a condition rarely met in clinical settings. As previous research has highlighted, inconsistent human annotations can compromise model performance, producing incorrect predictions and undermining clinical decision-support systems. Most studies have simply treated annotation imprecision as a limitation to acknowledge rather than a problem to solve. The CENTER-TBI team set out to close that methodological gap with a pragmatic framework that does not require an impossible gold standard, since no definitive ground truth exists for retrospective bedside notes.

The first step of the framework relies on human eyes. Because suctioning and physiotherapy leave short, recognisable fingerprints in the physiological record, such as transient spikes in arterial blood pressure and intracranial pressure, they serve as reference events. A reviewer visually inspected each patient file, tolerating timing errors of up to twenty minutes, and classified the file as showing high, moderate or low evidence of a genuine relationship between annotations and signals. Files with fewer than ten total annotations were automatically deemed low evidence. A second independent reviewer then checked the classifications, achieving substantial agreement, with a Cohen’s kappa of 0.69, and only seven of the 205 recordings required reclassification after consensus review.

The results of this visual screen were broadly reassuring: 60 percent of files showed high evidence, 30.2 percent moderate evidence and 9.8 percent low evidence. Within the high-evidence files, an independent event-level review of 1,769 suctioning annotations found that 91.3 percent were physiologically plausible. In other words, where bedside teams documented consistently, their notes generally matched what the waveforms showed. The framework’s authors argue that this kind of file-level screening can inject a degree of trust into interventions, such as fluid boluses or sedation changes, for which algorithmic validation is not feasible.

The second and third steps turned to automation, using osmotherapy, the administration of mannitol or hypertonic saline to lower dangerous intracranial pressure, as a test case. The algorithm searched a forty-minute baseline window around each of the 388 osmotherapy annotations for sustained intracranial hypertension, defined as pressure above 20 mm Hg for at least five consecutive minutes. Events lacking such a baseline were rejected as implausible. Of the 248 events that passed this filter, the post-intervention window was then assessed: 67.7 percent were classified as effective, showing either a pressure drop of at least 10 mm Hg or normalisation, while 32.3 percent were ineffective. The rejected events, 36.1 percent of the total, typically showed intracranial pressure stably below the treatment threshold both before and after the recorded time stamp, strongly suggesting the annotations did not reflect genuine treatment responses.

The most compelling evidence for the framework came from the convergence of its two independent strategies. Among osmotherapy events from high-evidence files, only 18 percent were rejected by the algorithm, compared with 44.1 percent from moderate-evidence files and 57.3 percent from low-evidence files, a highly significant difference that persisted across alternative pressure thresholds of 15 and 25 mm Hg. Two methods, one qualitative and human, one quantitative and automated, arrived at consistent verdicts, supporting the credibility of both. The study also found that annotation counts bore no significant relationship to patients’ six-month functional outcomes, and that documentation density peaked in the first 24 hours of intensive care before declining.

The researchers are careful about what their classifications mean. Treatment response is used here to separate plausible non-responders from annotations lacking a credible physiological context, not to judge the clinical efficacy of osmotherapy itself. Most ineffective events came from well-annotated files and showed prolonged pressure elevation, consistent with genuine treatment failure, whereas rejected events showed consistently low pressures. The team also acknowledges limitations: the framework cannot detect interventions performed but never documented, concurrent procedures can mimic reference signatures, and patients monitored exclusively with external ventricular drains were excluded because drain-open periods interrupt signal acquisition.

Beyond its immediate findings, the study carries a broader message for the era of clinical artificial intelligence. Until intensive care units systematically and automatically record medication types, doses and precise timings, manual annotations will remain the main bridge between physiological signals and clinical meaning, and that bridge needs inspection. The three-step framework, demonstrated for osmotherapy but applicable in principle to any intervention with definable physiological criteria, offers a practical audit tool. The authors call for external validation in other datasets and populations, but their conclusion is clear: in high-stakes neurocritical care, the data feeding tomorrow’s algorithms deserve the same scrutiny as the science built upon them.

Subject of Research: A methodological framework for evaluating the physiological plausibility of time-stamped clinical annotations in high-frequency neuromonitoring data from traumatic brain injury patients

Article Title: Time-Stamped Annotations in High-Frequency Physiological Data: Evaluating an Approach for Assessing Annotation Plausibility in the CENTER-TBI Dataset

Article References: Turella, S., Beqiri, E., Bögli, S. Y., Ianosi, B., Olakorede, I., Zoerle, T., Tas, J., Helbok, R., Smielewski, P., the Smart Neuromonitoring to Support Precision Medicine in Acute Central Nervous Injury (SOPRANI) collaborators and the CENTER-TBI High-Resolution Sub-Study Participants and Investigators, Anke, A., Beer, R., Helbok, R., Bellander, B.-M., Nelson, D., Buki, A., Chevallard, G., Chieregato, A., Citerio, G., … Rehber, C. (2026). Time-Stamped Annotations in High-Frequency Physiological Data: Evaluating an Approach for Assessing Annotation Plausibility in the CENTER-TBI Dataset. Neurocritical Care. https://doi.org/10.1007/s12028-026-02637-6

Image Credits: AI Generated

DOI: 10.1007/s12028-026-02637-6

Keywords: traumatic brain injury, CENTER-TBI, neurocritical care, neuromonitoring, clinical data annotation, osmotherapy, intracranial pressure, machine learning, data quality, ICU, physiological signals, artificial intelligence

The supplementary motor area, or SMA, is a strip of cortex on the medial surface of the frontal lobe, tucked anterior to the primary motor cortex and bounded by the superior frontal sulcus, the interhemispheric fissure, and the cingulate sulcus. It orchestrates the initiation and coordination of voluntary movement and contributes to speech fluency. Because frontal gliomas frequently invade or abut this region, surgeons operating there routinely risk provoking the syndrome, which classically presents as contralateral weakness or slowness of movement, impaired motor initiation, mutism or reduced verbal output, and a striking general reduction in spontaneous activity. Previous reports have placed its incidence anywhere between 23 and 100 percent depending on the tumor type and surgical definition, with one prominent series reporting 60.7 percent in SMA-involving glioma resections.

The Munich team, led by Dragan Jankovic and Darius Kalasauskas, set out to answer a question that had never been systematically addressed: does this dramatic postoperative deficit actually matter for oncological outcomes? The concern is clinically grounded. Functional status is one of the strongest prognostic factors in glioma care, because patients must be well enough to tolerate radiotherapy and chemotherapy within the narrow window of roughly four to six weeks after surgery. If SMA syndrome knocked patients below the eligibility thresholds for standard treatment protocols, it could indirectly cost them survival time even if the deficit itself was harmless.

To find out, the researchers reviewed 74 consecutive patients who underwent resection of gliomas involving, adjacent to, or approached through the SMA between 2015 and 2024. The cohort spanned World Health Organization grades 2 through 4, from slower-growing IDH-mutant tumors to aggressive IDH-wildtype glioblastoma. The team defined SMA syndrome strictly: new-onset motor deficits or language impairment without corresponding changes in intraoperative neuromonitoring, and without imaging or surgical evidence of injury to the primary motor cortex, the corticospinal tract, or ischemia. This definition matters, because it separates a network-level functional disruption from direct structural damage to the brain’s motor highways.

Half of the patients, 37 of 74, developed the syndrome after surgery. That figure alone is striking, but the recovery pattern was equally notable. By the first outpatient follow-up, at a median of 43 days, 81 percent of affected patients had fully recovered, and both groups had returned to a median Karnofsky Performance Status of 90. The syndrome, in other words, was overwhelmingly transient, consistent with the idea that the SMA’s functions are redistributed across parallel motor networks once the acute postoperative disruption subsides.

The statistical analysis, using logistic and Cox regression models adjusted for age, preoperative functional status, and tumor volume, delivered the study’s central message. Postoperative SMA syndrome was not associated with delayed initiation of adjuvant therapy, with a hazard ratio of 0.86 and a p-value of 0.617. It did not predict worse progression-free survival, with a hazard ratio of 1.21 and a p-value of 0.573, and it did not predict worse overall survival, with a hazard ratio of 1.21 and a p-value of 0.681. Kaplan-Meier curves for both survival endpoints overlapped almost completely between patients with and without the syndrome. Even the small subgroup of seven patients whose deficits persisted at follow-up showed no statistically significant survival disadvantage, although the authors caution that this exploratory finding rests on very limited numbers.

What did predict the syndrome? The extent of resection, classified according to the RANO resection system, emerged as the key risk factor. Compared with supramaximal RANO class 1 resections, class 2 resections, encompassing complete and near-total removal of contrast-enhancing or T2-FLAIR-visible tumor, carried roughly fivefold higher odds of postoperative SMA syndrome in the multivariable model, with an odds ratio of 5.05 and a p-value of 0.024. The authors interpret this not as a reason to stop short of maximal resection, but as a reflection of the anatomical reality: class 2 resections frequently represent the limit of what is safe when tumors press against eloquent motor pathways, including the corticospinal tract and the frontal aslant tract, a fiber bundle previously implicated in both the occurrence and the recovery of SMA syndrome.

Perhaps the most clinically consequential finding concerns what actually drives treatment decisions. Patients whose Karnofsky score dropped by 20 points or more after surgery were far more likely to receive modified or reduced-intensity adjuvant therapy, with an adjusted odds ratio of 13.91 and a p-value of 0.005. Yet SMA syndrome itself was not associated with treatment modification at all. The distinction is subtle but important: a global decline in functional status, which may stem from frailty, delayed recovery, reduced mobility, or systemic complications such as pneumonia, is what makes oncologists and tumor boards recalibrate therapy, not the specific neurological signature of SMA syndrome. Decision-makers, the authors suggest, calibrate treatment to overall functional reserve rather than to any particular deficit phenotype.

The study also reinforces a growing mechanistic understanding of why the syndrome occurs and why it resolves. Intraoperative neuromonitoring changes were rare and showed no association with the syndrome, supporting the concept that SMA syndrome arises from disruption of higher-order motor networks, including interhemispheric connections through the corpus callosum, rather than from injury to the corticospinal tract that standard monitoring interrogates. Previous work has shown that recovery from the syndrome is predicted by restoration of this interhemispheric SMA connectivity, a pathway that is anatomically distinct from the motor tract and invisible to conventional neuromonitoring. This network-level explanation fits neatly with the predominantly transient course observed in Munich.

The authors are candid about the limitations. The retrospective design may have undercounted subtle or short-lived manifestations, particularly mild language disturbances. Karnofsky scores are a blunt instrument for capturing SMA-specific deficits. Diffusion tensor tractography was not systematically available, leaving the spatial relationship between tumors and functional pathways unquantified. The single-center cohort of 74 patients limits statistical power, as reflected in wide confidence intervals, and the mixed tumor grades required two different RANO classification frameworks. Still, the consistency of the findings across univariate, multivariable, and Kaplan-Meier analyses lends weight to the conclusion. For patients facing glioma surgery near the supplementary motor area, the message is cautiously optimistic: the frightening postoperative shutdown that surgeons have feared since the era of Penfield is, in oncological terms, a detour rather than a dead end, and it should not deter maximal safe resection when the tumor demands it.

Subject of Research: The impact of postoperative supplementary motor area syndrome on adjuvant therapy timing and survival in intracranial glioma surgery

Article Title: Supplementary motor area syndrome in intracranial gliomas is not associated with worse survival

Article References: Supplementary motor area syndrome in intracranial gliomas is not associated with worse survival. (n.d.). https://doi.org/10.1007/s11060-026-05805-y

Image Credits: AI Generated

DOI: 10.1007/s11060-026-05805-y

Keywords: supplementary motor area, SMA syndrome, glioma, glioma surgery, adjuvant therapy, progression-free survival, overall survival, Karnofsky Performance Status, neuromonitoring, extent of resection, neuro-oncology, neurosurgery

The scale of the physiological transformation is striking. The most common technique, decompressive hemicraniectomy, involves removing a bone flap averaging 14 by 14 centimeters and opening the dura widely, which enlarges the cranial cavity by an estimated 120 to 200 milliliters. A meta-analysis cited in the viewpoint quantified the immediate effect: intracranial pressure drops by an average of 17.59 millimeters of mercury, a reduction sustained at 24 and 48 hours, while cerebral perfusion pressure rises by 7.37 millimeters of mercury. Cerebral blood flow and brain tissue oxygenation typically improve as well. But the surgery also produces a cascade of adverse changes: rapid outward brain expansion, impaired cerebrovascular autoregulation, disrupted cerebrospinal fluid dynamics that predispose patients to hydrocephalus, altered intracranial pressure waveform morphology, and even cardiovascular effects mediated through autonomic mechanisms.

The central paradox the authors highlight is that decompressive craniectomy is a temporizing hemodynamic intervention. It relieves the mechanical consequences of high intracranial pressure but does nothing to reverse the underlying structural brain injury. This means the rationale for continued invasive neuromonitoring remains as strong as ever, despite lingering skepticism in some centers that clinical assessment and neuroimaging suffice once the skull is open. Two major consensus statements support continued monitoring: the Milan Consensus Conference recommended intracranial pressure monitoring after secondary decompressive craniectomy to assess the effectiveness of the surgery and guide further therapy, and an international neurosurgical consensus stated that monitoring and treatment should continue until pressure values remain controlled and stable.

The empirical data make a compelling case. Observational studies show that intracranial hypertension persists or recurs in 36 to 76.5 percent of traumatic brain injury patients after decompressive craniectomy, with similar rates reported after surgery for malignant middle cerebral artery infarction. The rationale for continued monitoring includes persistence of the underlying pathophysiology, the risk of recurrent intracranial hypertension or de novo hematomas, and the need to rationalize therapies such as osmotherapy, sedation, and cerebrospinal fluid drainage. The authors also draw a critical distinction between primary decompressive craniectomy, performed as the first intervention, and secondary surgery after conventional pressure management fails. The greatest lesion evolution occurs in the first 8 to 12 hours after the initial insult, a window that coincides with the early postoperative period in primary cases where no prior monitoring was in place. Contralateral epidural hematoma, a well-recognized complication, occurs predominantly after primary surgery, providing an additional argument for sustained surveillance.

Where exactly to place the pressure sensor turns out to be a question with no evidence-based answer. Neither current consensus statements nor major decompressive craniectomy trials report data on sensor implantation site. The limited published series favor ipsilateral placement, on the reasoning that intracranial pressure is compartmentalized, interhemispheric pressure gradients may develop, and regional hypertension can persist or emerge despite decompression. The authors stress that this recommendation rests on pathophysiological reasoning rather than high-quality prospective evidence. Contralateral placement risks underestimating true pressure and brain tissue oxygenation, leaving focal hypoxia or hypertension undetected, though specific scenarios may warrant it: extensive hemispheric parenchymal destruction, large hemorrhages with marked midline shift, diffuse bilateral injury, a nonviable ipsilateral surgical trajectory, infection of pre-existing sensors, or post-primary surgery where no prior monitoring exists.

The choice of monitoring modality adds another layer of complexity. External ventricular drains offer both pressure measurement and therapeutic cerebrospinal fluid diversion but can be technically challenging after surgery because of ventricular distortion. Intraparenchymal probes are easier to deploy but provide only regional measurements without drainage capability. The authors suggest a staged approach, beginning with an ipsilateral parenchymal probe and adding a contralateral ventricular drain in selected patients. Meanwhile, the evidence base for noninvasive monitoring in the decompressed brain remains sparse and contradictory. Optic nerve sheath diameter ultrasonography has shown that postoperative reductions correlate with outcome in malignant stroke and traumatic brain injury, yet other studies report poor performance of both this technique and transcranial Doppler for estimating pressure and perfusion after surgery. The discrepancies likely reflect heterogeneous reference standards, variable timing of measurements, and the fact that optic nerve sheath measurements reflect global rather than regional pressure dynamics.

Even electroencephalography becomes harder to interpret in these patients. The skull defect produces the so-called breach rhythm, high-voltage physiological waveforms that can mimic epileptiform discharges, while magnetoencephalography is less affected by the missing bone. Near-infrared spectroscopy demonstrated significant bilateral improvement in cerebral oxygen saturation after surgery for malignant infarction, though only contralateral changes correlated with 30-day outcome. Novel noninvasive devices that detect cranial vault micro-expansions to reconstruct pressure waveforms are particularly controversial in the absence of a bone flap, and an artificial intelligence-based pulse shape index for classifying intracranial compliance requires especially cautious interpretation in this population. A systematic review and meta-analysis concluded that invasive and noninvasive methods show similar effectiveness after decompressive craniectomy, and a prospective study by Alhamdan and colleagues demonstrated that invasive monitoring provides significant prognostic information after malignant infarction, with autonomic indices such as heart rate variability, baroreflex sensitivity, and signal complexity potentially complementing standard pressure data.

Perhaps the most provocative section of the viewpoint concerns treatment thresholds. Current Brain Trauma Foundation and Seattle International consensus guidelines recommend initiating treatment for intracranial hypertension at pressures above 22 millimeters of mercury, recommendations based on low-level evidence and extrapolated to decompressed patients despite fundamental physiological differences. Multiple observational studies now challenge this. A large prospective analysis identified 19 millimeters of mercury as the value most strongly associated with outcome, a finding maintained in patients undergoing decompressive craniectomy. After surgery for malignant infarction, Hernández-Durán and colleagues found 10 millimeters of mercury as the threshold most strongly associated with mortality, and in a comparable population pressures above 15 millimeters of mercury correlated with unfavorable outcomes, as did a pressure reactivity index near zero or perfusion pressure below 80 millimeters of mercury. A retrospective traumatic brain injury analysis using a 15-millimeter treatment threshold found Glasgow Outcome Scale Extended scores of 1 versus 5 depending on whether pressures exceeded 25 millimeters, and identified 40 millimeters of mercury as the functional lower limit of cerebral perfusion pressure.

A German retrospective cohort that monitored pressures for seven days after surgery adds further weight. Favorable outcomes corresponded to pressures that never exceeded 14 millimeters of mercury, with a mean of 11.5, while unfavorable outcomes corresponded to a mean of 17.5 millimeters, with statistical significance for both traumatic brain injury and malignant infarction independently. Kaplan-Meier analysis showed 75 percent versus 40 percent survival probability respectively. The authors are careful to note that all these data are exclusively retrospective, small-sample, and heterogeneous, and must be considered hypothesis-generating rather than practice-defining. Still, the pattern is consistent: clinically relevant deterioration appears to occur at substantially lower pressures in the decompressed brain than conventional guidelines assume.

The viewpoint distills the problem into six key physiological differences that undermine extrapolation from intact-skull physiology: abolition of the closed-box condition negates the Monro-Kellie doctrine and profoundly alters the pressure-volume relationship; cerebrospinal fluid dynamics are disrupted with predisposition to hydrocephalus; pressure waveform morphology and pulse amplitude characteristics are fundamentally changed; interhemispheric pressure gradients may render single-site measurements unrepresentative; autoregulatory indices require reinterpretation in the altered compliance environment; and noninvasive tools relying on acoustic or mechanical coupling through an intact skull lose reliability without a bone flap. The authors call for prospective, standardized research to fill these gaps and suggest that, in the interim, a structured consensus-based approach could harmonize clinical practice and identify research priorities. For a procedure performed thousands of times each year worldwide, the message is sobering: the brain without its skull is, in monitoring terms, an almost entirely uncharted organ.

Subject of Research: Neuromonitoring physiology and intracranial pressure thresholds after decompressive craniectomy

Article Title: Neuromonitoring in the Decompressed Brain: Rethinking Physiology, Monitoring, and Thresholds After Decompressive Craniectomy

Article References: Godoy, D. A., Paiva, W. S., de Amorim, R. L. O., Rovegno, M., & Rubiano, A. M. (2026). Neuromonitoring in the Decompressed Brain: Rethinking Physiology, Monitoring, and Thresholds After Decompressive Craniectomy. Neurocritical Care. https://doi.org/10.1007/s12028-026-02622-z

Image Credits: AI Generated

DOI: 10.1007/s12028-026-02622-z

Keywords: decompressive craniectomy, intracranial pressure, neuromonitoring, cerebral perfusion pressure, traumatic brain injury, malignant cerebral infarction, neurocritical care, ICP thresholds, sensor placement, noninvasive monitoring, cerebral autoregulation, Monro-Kellie doctrine